ONCASPAR
- Name: ONCASPAR
- Generic Name : Pegaspargase
- Strength: Units/5 mL solution in a single-use vial.
- Manufactured: BAXALTA US INC.
Oncaspar (Pegaspargase) is an asparagine specific enzyme used as a component of a multi-agent chemotherapeutic regimen for treatment of patients with:
- First line acute lymphoblastic leukemia.
- Acute lymphoblastic leukemia and hypersensitivity to asparaginase.
- Observe patients for 60 minutes after administration of oncaspar 3750 in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (for example, oxygen, epinephrine, intravenous steroids, antihistamines).
- Severe thrombotic events, including sagittal sinus thrombosis can occur in patients receiving pegaspargase injection. Discontinue it in patients with serious thrombotic events.
- Pancreatitis may develop in patients receiving Oncaspar. Assess patients with abdominal pain for evidence of pancreatitis. Discontinue oncaspar injection in patients with pancreatitis.
- Glucose intolerance may develop in patients with the therapy of Oncaspar. In some cases, glucose intolerance is irreversible.
- Patients with pegaspargase dosage should be monitored for coagulation parameters at baseline and periodically while on and following treatment.
What documents are required to import ONCASPAR to India?
ONCASPAR (Pegaspargase 3,750 International Units/5mL) can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is ONCASPAR available in India?
ONCASPAR is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
ONCASPAR (Pegaspargase 3750) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of ONCASPAR (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for oncaspar price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the ONCASPAR (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Oncaspar® ?
Pegaspargase is Generic Name for the trade name drug Oncaspar®.
What is the Manufacturer Name of Oncaspar®?
Oncaspar® is manufactured by BAXALTA US, Inc.
Is Oncaspar® approved by the FDA?
Yes, Oncaspar® is approved by the FDA. Date of approval: February 1994.
What is the dosage and form of Oncaspar® available?
Oncaspar® is available as 3,750 International Units/5 mL solution in a single-use vial.
What are the most commonly reported side effects of Pegaspargase?
The most commonly reported pegaspargase side effects include central nervous system (CNS) thrombosis, coagulopathy, elevated transaminases, hyperbilirubinemia, allergic reactions (including anaphylaxis), pancreatitis and hyperglycemia.
What are the storage conditions of Oncaspar®?
This medicinal product should be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Do not shake or freeze it. Protect from light. Do not use it after the expiration date on the vial.
How much does Oncaspar® cost in India?
You can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in to know the Oncaspar cost.
What are the Highlights of prescribing information for Oncaspar®?
Click Here to download full Oncaspar Oprescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.